AAAAAA
Results: 26-32/32
Authors:
Lagrand, WK
Visser, CA
Hermens, WT
Niessen, HWM
Verheugt, FWA
Wolbink, GJ
Hack, CE
Citation: Wk. Lagrand et al., C-reactive protein as a cardiovascular risk factor - More than an epiphenomenon?, CIRCULATION, 100(1), 1999, pp. 96-102
Authors:
Lamfers, EJP
Hooghoudt, TEH
Uppelschoten, A
Stolwijk, PWJ
Verheugt, FWA
Citation: Ejp. Lamfers et al., Effect of prehospital thrombolysis on aborting acute myocardial infarction, AM J CARD, 84(8), 1999, pp. 928
Authors:
Veen, G
de Boer, MJ
Zijlstra, F
Verheugt, FWA
Citation: G. Veen et al., Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial), AM J CARD, 84(7), 1999, pp. 763-767
Authors:
Spiecker, M
Windeler, J
Vermeer, F
Michels, R
Seabra-Gomes, R
vom Dahl, J
Kerber, S
Verheugt, FWA
Westerhof, PW
Bar, FW
Nixdorff, U
Barth, H
Hopkins, GR
von Fisenne, MJM
Meyer, J
Citation: M. Spiecker et al., Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: Five-year results of the PRIMI Trial, AM HEART J, 138(3), 1999, pp. 518-524
Authors:
Verheugt, FWA
Bar, FWHM
Citation: Fwa. Verheugt et Fwhm. Bar, Introducing a new thrombolytic for the routine management of acute myocardial infarction - Introduction, INT J CL PR, 1998, pp. 2-2
Authors:
Verheugt, FWA
Citation: Fwa. Verheugt, What should a new thrombolytic bring us?, INT J CL PR, 1998, pp. 3-5
Authors:
Verheugt, FWA
Citation: Fwa. Verheugt, Heparin for acute myocardial infarction: "News" from the "past" - Reply, J AM COL C, 32(7), 1998, pp. 2102-2102